Sign in
About
Ethics Policy
Privacy Policy
Refund Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Thursday, March 5, 2026
Sign in / Join
About
Ethics Policy
Privacy Policy
Refund Policy
Facebook
Instagram
Twitter
Vimeo
Youtube
About
Ethics Policy
Privacy Policy
Refund Policy
Search
LATEST ARTICLES
Press Release
Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
Team Business Headline
-
December 9, 2025
0
Press Release
Netcapital Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Team Business Headline
-
December 9, 2025
0
Press Release
Cygnus Metals Limited: Issue of Performance Rights
Team Business Headline
-
December 9, 2025
0
Press Release
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
Team Business Headline
-
December 8, 2025
0
Press Release
Cochin Shipyard to build next-generation electric TRAnsverse tugs for Svitzer
Team Business Headline
-
December 8, 2025
0
Press Release
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The FX Super One First Pre-Production Vehicles Roll-off Ceremony is Scheduled for December...
Team Business Headline
-
December 8, 2025
0
Press Release
Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect
Team Business Headline
-
December 8, 2025
0
Press Release
ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patients with Myeloid Malignances
Team Business Headline
-
December 8, 2025
0
Press Release
Balancer Announcement: If You Have Suffered Losses in Balancer Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Team Business Headline
-
December 7, 2025
0
Press Release
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease...
Team Business Headline
-
December 7, 2025
0
1
...
45
46
47
...
287
Page 46 of 287
Most Popular
Decisions of the Extraordinary General Meeting of shareholders of Nordic Fibreboard AS
March 4, 2026
Director/PDMR Shareholding
March 4, 2026
Final Results
March 4, 2026
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
March 4, 2026
Load more
Recent Comments
yearlymagazine
on
Market: Ola Electric Mobility Shares Tank 5% Today
yearlymagazine
on
Future of Startup Funding in 2025: A Steady Rebound with a Focus on Sustainable Growth
yearlymagazine
on
Future of Startup Funding in 2025: A Steady Rebound with a Focus on Sustainable Growth
yearlymagazine
on
Unimech Aerospace and Manufacturing IPO: Stellar Response and Strong Grey Market Performance
influencersginewuld
on
12 Indian Startups That Shut Down This Year: Report
error:
Recent Comments